Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Inotuzumab_ozogamicin> ?p ?o }
Showing triples 1 to 73 of
73
with 100 triples per page.
- Inotuzumab_ozogamicin abstract "Inotuzumab ozogamicin (CMC-544) is an antibody-drug conjugate for the treatment of cancers. It consists of the humanized monoclonal antibody inotuzumab (for CD22), linked to a cytotoxic agent from the class of calicheamicins (which is reflected by 'ozogamicin' in the drug's name).This drug is being developed by Pfizer and UCB.It is undergoing numerous clinical trials, including two phase II trials for Non-Hodgkin lymphoma (NHL). A phase III trial in patients with follicular b-cell NHL has been terminated due to poor enrollment.A Phase III trial in patients with relapsed or refractory CD22+ aggressive non-Hodgkin lymphoma (NHL) who were not candidates for intensive high-dose chemotherapy was terminated for futility.".
- Inotuzumab_ozogamicin atcPrefix "none".
- Inotuzumab_ozogamicin casNumber "635715-01-4".
- Inotuzumab_ozogamicin fdaUniiCode "P93RUU11P7".
- Inotuzumab_ozogamicin wikiPageID "9685856".
- Inotuzumab_ozogamicin wikiPageLength "3333".
- Inotuzumab_ozogamicin wikiPageOutDegree "15".
- Inotuzumab_ozogamicin wikiPageRevisionID "707384165".
- Inotuzumab_ozogamicin wikiPageWikiLink Antibody-drug_conjugate.
- Inotuzumab_ozogamicin wikiPageWikiLink CD22.
- Inotuzumab_ozogamicin wikiPageWikiLink Calicheamicin.
- Inotuzumab_ozogamicin wikiPageWikiLink Category:Antibody-drug_conjugate.
- Inotuzumab_ozogamicin wikiPageWikiLink Category:Monoclonal_antibodies_for_tumors.
- Inotuzumab_ozogamicin wikiPageWikiLink Category:Wyeth.
- Inotuzumab_ozogamicin wikiPageWikiLink Cytotoxicity.
- Inotuzumab_ozogamicin wikiPageWikiLink Gemtuzumab_ozogamicin.
- Inotuzumab_ozogamicin wikiPageWikiLink Humanized_antibody.
- Inotuzumab_ozogamicin wikiPageWikiLink Non-Hodgkin_lymphoma.
- Inotuzumab_ozogamicin wikiPageWikiLink Ozogamicin.
- Inotuzumab_ozogamicin wikiPageWikiLink Pfizer.
- Inotuzumab_ozogamicin wikiPageWikiLink UCB_(company).
- Inotuzumab_ozogamicin wikiPageWikiLinkText "Inotuzumab ozogamicin".
- Inotuzumab_ozogamicin wikiPageWikiLinkText "inotuzumab ozogamicin".
- Inotuzumab_ozogamicin atcPrefix "none".
- Inotuzumab_ozogamicin c "6518".
- Inotuzumab_ozogamicin casNumber "635715".
- Inotuzumab_ozogamicin chemspiderid "none".
- Inotuzumab_ozogamicin h "10002".
- Inotuzumab_ozogamicin kegg "D08933".
- Inotuzumab_ozogamicin mabType "mab".
- Inotuzumab_ozogamicin molecularWeight "150000".
- Inotuzumab_ozogamicin n "1738".
- Inotuzumab_ozogamicin o "2036".
- Inotuzumab_ozogamicin s "42".
- Inotuzumab_ozogamicin source "zu/o".
- Inotuzumab_ozogamicin target CD22.
- Inotuzumab_ozogamicin type "mab".
- Inotuzumab_ozogamicin unii "P93RUU11P7".
- Inotuzumab_ozogamicin verifiedfields "changed".
- Inotuzumab_ozogamicin verifiedrevid "458271836".
- Inotuzumab_ozogamicin wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Inotuzumab_ozogamicin wikiPageUsesTemplate Template:Cascite.
- Inotuzumab_ozogamicin wikiPageUsesTemplate Template:Chemspidercite.
- Inotuzumab_ozogamicin wikiPageUsesTemplate Template:Drugbankcite.
- Inotuzumab_ozogamicin wikiPageUsesTemplate Template:Drugbox.
- Inotuzumab_ozogamicin wikiPageUsesTemplate Template:Fdacite.
- Inotuzumab_ozogamicin wikiPageUsesTemplate Template:Keggcite.
- Inotuzumab_ozogamicin wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Inotuzumab_ozogamicin wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Inotuzumab_ozogamicin subject Category:Antibody-drug_conjugate.
- Inotuzumab_ozogamicin subject Category:Monoclonal_antibodies_for_tumors.
- Inotuzumab_ozogamicin subject Category:Wyeth.
- Inotuzumab_ozogamicin hypernym Conjugate.
- Inotuzumab_ozogamicin type ChemicalSubstance.
- Inotuzumab_ozogamicin type Company.
- Inotuzumab_ozogamicin type Drug.
- Inotuzumab_ozogamicin type Antibody.
- Inotuzumab_ozogamicin type Chemical.
- Inotuzumab_ozogamicin type Company.
- Inotuzumab_ozogamicin type Drug.
- Inotuzumab_ozogamicin type ChemicalObject.
- Inotuzumab_ozogamicin type Thing.
- Inotuzumab_ozogamicin type Q8386.
- Inotuzumab_ozogamicin comment "Inotuzumab ozogamicin (CMC-544) is an antibody-drug conjugate for the treatment of cancers. It consists of the humanized monoclonal antibody inotuzumab (for CD22), linked to a cytotoxic agent from the class of calicheamicins (which is reflected by 'ozogamicin' in the drug's name).This drug is being developed by Pfizer and UCB.It is undergoing numerous clinical trials, including two phase II trials for Non-Hodgkin lymphoma (NHL).".
- Inotuzumab_ozogamicin label "Inotuzumab ozogamicin".
- Inotuzumab_ozogamicin sameAs Q3799041.
- Inotuzumab_ozogamicin sameAs إينوتوزوماب_أوزوغاميسين.
- Inotuzumab_ozogamicin sameAs Inotuzumab_ozogamicin.
- Inotuzumab_ozogamicin sameAs イノツズマブ_オゾガマイシン.
- Inotuzumab_ozogamicin sameAs m.02pp2z1.
- Inotuzumab_ozogamicin sameAs Q3799041.
- Inotuzumab_ozogamicin wasDerivedFrom Inotuzumab_ozogamicin?oldid=707384165.
- Inotuzumab_ozogamicin isPrimaryTopicOf Inotuzumab_ozogamicin.